TP53 and neoplasm: In 2011, the same research group analyzed 10 pairs of pre- and posttreatment cervical tumor samples by microarray analysis and stated that combinational hydralazine/valproate application in patients upregulated 964 genes associated with energy production and, by extension, tumor suppression, as well as increased acetylated p53 [95].